Managing Director No Haeseong acquires 87,057 shares via convertible bond call option... conversion price at 1,723 won, 54% discount to market, posing dilution risk to existing shareholders
Managing Director No Haeseong (non-registered executive) of GENINUS was designated by the company as the call option holder for the 1st private convertible bonds on May 22, 2026, thereby acquiring 87,057 shares in the form of convertible bonds.
The conversion price is 1,723 won, representing a 54% discount to the closing price of 3,735 won on the report base date (May 29, 2026). This effectively constitutes a low-priced issuance, diluting existing shareholders' value.
The acquired amount is only 0.22% of total issued shares (39,304,362), so the immediate impact is limited, but upon conversion, these shares could be sold in the market, adding supply.
[AI Comprehensive Analysis]This disclosure involves a small share change that has minimal direct impact on the stock price. However, providing an insider with a conversion opportunity at a price significantly below market may be perceived as unfair by minority shareholders. Investors should watch for potential further dilution if the conversion price is adjusted downward.
KOSDAQ Filing Information
Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders